1. Lucentis is the first FDA-approved treatment for diabetic retinopathy patients with or without diabetic macular edema.
2. Tecentriq can now be used to treat patients with advanced bladder cancer who are not eligible for standard chemotherapy.
3. Cardea Solo is a wearable electrocardiogram sensor used to diagnose heart arrhythmias.
4. GammaCore is a handheld device used to treat cluster headaches.
More articles on supply chain:
Global pharmerging market to reach $1.4B by 2025
Price hikes likely added $8.7B to pharma’s net income for 2016, report finds
ASCO: Strategies to control drug costs hinder cancer patient care
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
